Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing (Q36289418)

13 August 2017

1 reference

title

Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing (English)

1 reference

13 August 2017

1 reference

Anthony J Busti

1

1 reference

13 August 2017

Justin S Hooper

series ordinal

2

1 reference

13 August 2017

Christopher J Amaya

series ordinal

3

1 reference

13 August 2017

Salahuddin Kazi

series ordinal

4

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

13 August 2017

1 reference

13 August 2017

25

1 reference

13 August 2017

11

1 reference

13 August 2017

1566-1591

1 reference

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

13 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Leflunomide-associated pancytopenia with or without methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Healing responses of skin and muscle in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Growth factors and wound healing: Part II. Role in normal and chronic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Role of growth factors in inflammation and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The effects of drugs on wound healing--part II. Specific classes of drugs and their effect on healing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The stimulatory effect of prostaglandins on production of hexosamine-containing substances by cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Stimulatory effect of prostaglandins on the production of hexosamine-containing substance by cultured fibroblasts (3) induction of hyaluronic acid synthetase by prostaglandin F2α

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Selective cyclooxygenase-2 inhibition does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Cyclo-oxygenase 2 function is essential for bone fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Cyclooxygenase-2 inhibitor inhibits the fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Molecular therapeutics. Methotrexate and its mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Polyglutamation of methotrexate. Is methotrexate a prodrug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Perioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Control of Wound Healing and Scar Formation in Surgical Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Skin Collagen Biosynthesis In Patients With Rheumatoid Arthritis Treated With D-Penicillamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Mechanism of action for leflunomide in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The safety of anakinra in high-risk patients with active rheumatoid arthritis: six-month observations of patients with comorbid conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Mechanisms of action of glucocorticoids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Effects of Cortisone Acetate, Methylprednisolone and Medroxyprogesterone on Wound Contracture and Epithelization in Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Mycophenolate mofetil impairs healing of left-sided colon anastomoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

TRANSPARENT SKIN AND OSTEOPOROSIS: A STUDY IN PATIENTS WITH RHEUMATOID DISEASE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The effects of drugs on wound healing: part 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

The effect of antimicrobial agents on leukocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Corticosteroid insufficiency in acutely ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Corticosteroid supplementation for adrenal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

Effect of indomethacin on fracture healing in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.11.1566

10.1592/PHCO.2005.25.11.1566

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference